Aurinia Pharmaceuticals Inc

(NASDAQ:AUPH)

Latest On Aurinia Pharmaceuticals Inc (AUPH):

Date/Time Type Description Signal Details
2023-05-22 04:58 ESTNewsAurinia: Despite Milder Shareholder Vote, A Bid To Sell Is Still Not OverN/A
2023-05-18 03:27 ESTNewsAurinia Pharmaceuticals gains as two board members resign amid holder voteN/A
2023-05-11 16:54 ESTNewsAurinia Pharma's largest holder to oppose seven director nominationsN/A
2023-05-04 22:29 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:27 ESTNewsAurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29MN/A
2023-05-04 09:27 ESTNewsAurinia Pharma gains after Q1 beat and guidance raiseN/A
2023-05-03 21:13 ESTNewsAurinia wins U.K. nod for lupus nephritis therapy LupkynisN/A
2023-05-03 21:13 ESTNewsAurinia Pharma Q1 2023 Earnings PreviewN/A
2023-04-24 15:43 ESTNewsAurinia Pharma shareholder says company should put itself up for saleN/A
2023-04-05 19:20 ESTNewsAurinia's Lupkynis shows promise in 18-month kidney biopsy dataN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals gains amid renewed takeover speculationN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: All In On Lupkynis - A Tough BetN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock ValueN/A
2023-03-23 15:36 ESTNewsAurinia Pharmaceuticals Has Strong Upside PotentialN/A
2023-03-22 08:08 ESTNewsAurinia Pharmaceuticals' Lupkynis Faces Challenges In Lupus Nephritis MarketN/A
2023-02-28 16:56 ESTNewsAurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlookN/A
2023-02-28 16:56 ESTNewsAurinia stock rises as Q4 loss narrows, Lupkynis revenue grows; reaffirms product outlookN/A
2023-02-28 16:56 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:47 ESTNewsAurinia Pharma Q4 2022 Earnings PreviewN/A
2023-01-25 14:02 ESTNewsAurinia adds 11% amid patent wins in the U.S. and EUN/A
2023-01-06 09:17 ESTNewsAurinia Pharmaceuticals guides Q4 revenue above estimatesN/A
2023-01-05 20:19 ESTNewsAurinia Pharmaceuticals: Lupkynis Patent Settlement Removes OverhangN/A
2023-01-05 20:19 ESTNewsAurinia's Patent Dispute Is Over, But Without A Buyout, There's No UpsideN/A
2023-01-04 16:36 ESTNewsAurinia Pharmaceuticals gains amid M&A speculation following patent settlementN/A
2023-01-03 13:05 ESTNewsAurinia shares jump 36% on patent challenge settlement with India's Sun PharmaN/A
2022-12-01 07:15 ESTNewsAurinia's lupus nephritis drug Lupkynis gets approval in UKN/A
2022-11-06 23:23 ESTNewsAurinia: A Commercial Stage Company With Major HeadwindsN/A
2022-11-03 23:28 ESTNewsAurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38MN/A
2022-11-03 23:28 ESTNewsAurinia sheds 22% as lackluster Lupkynis uptake leads to guidance cutN/A
2022-11-03 23:28 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 13:46 ESTNewsAurinia Pharma Q3 2022 Earnings PreviewN/A
2022-10-21 20:09 ESTNewsAurinia announces resignations of medical chief and senior research executiveN/A
2022-10-21 20:09 ESTNewsAurinia defended at H.C. Wainwright after key resignationsN/A
2022-09-19 19:15 ESTNewsAurinia Pharmaceuticals wins European approval of Lupkynis for lupusN/A
2022-08-24 17:12 ESTNewsAurinia Pharmaceuticals: The Right Play NowN/A
2022-08-16 04:35 ESTNewsAurinia Pharmaceuticals: Updating My Revenue And Valuation ModelN/A
2022-08-04 23:37 ESTNewsAurinia Pharmaceuticals Inc's (AUPH) CEO Peter Greenleaf on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 08:03 ESTNewsAurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16MN/A
2022-08-04 08:02 ESTNewsAurinia narrows 2Q net loss as Lupkynis sales regain momentumN/A
2022-08-03 17:35 ESTNewsAurinia Pharma Q2 2022 Earnings PreviewN/A
2022-07-26 13:19 ESTNewsPatent challenge on Aurinia's Lupkynis could impact takeover interest near-term - CantorN/A
2022-07-22 12:15 ESTNewsAurinia lupus nephritis drug recommended in EuropeN/A
2022-07-16 02:36 ESTNewsAurinia Pharma tumbles after takeover speculation cools on new exec hires, exec departureN/A
2022-07-04 17:27 ESTNewsA Buyout-Driven Pair Trade: Buy Aurinia, Sell Merck (Or Seagen If You Must)N/A
2022-07-01 19:17 ESTNewsAurinia Pharmaceuticals gains on speculation of Otsuka interestN/A
2022-05-24 14:21 ESTNewsAurinia Pharmaceuticals: Some Red Flags To Consider From Q1 2022 EarningsN/A
2022-05-22 11:59 ESTNewsAurinia: Redemption On Lupkynis Sales And Possible EMA ApprovalN/A
2022-05-20 13:35 ESTNewsAurinia Pharmaceuticals touts long-term benefit of Lupkynis for lupusN/A
2022-05-11 00:20 ESTNewsAurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39MN/A
2022-05-11 00:20 ESTNewsAurinia Pharma in focus despite 1Q revenue beat as Omicron hurts Lupkynis salesN/A

About Aurinia Pharmaceuticals Inc (AUPH):

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

See Advanced Chart

General

  • Name Aurinia Pharmaceuticals Inc
  • Symbol AUPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 294
  • Last Split Factor1:50
  • Last Split Date2013-10-23
  • Fiscal Year EndDecember
  • IPO Date1999-01-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.auriniapharma.com
View More

Valuation

  • Forward PE 1428.57
  • Price/Sales (Trailing 12 Mt.) 33.99
  • Price/Book (Most Recent Quarter) 4.49
  • Enterprise Value Revenue 28.78
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -205%
  • Operating Margin -208%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 50.12 million
  • Earnings Per Share -$0.70
  • Revenue Per Share $0.42
  • Gross Profit -209000
  • Quarterly Earnings Growth 172417.2%
View More

Highlights

  • Market Capitalization 1.72 billion
  • EBITDA -58641000
  • Analyst Target Price $11.5
  • Book Value Per Share $3.22
View More

Share Statistics

  • Shares Outstanding 127.45 million
  • Shares Float 116.02 million
  • % Held by Insiders 978%
  • % Held by Institutions 55.87%
  • Shares Short 5.95 million
  • Shares Short Prior Month 5.44 million
  • Short Ratio 1.21
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.47
  • 52 Week High $18.72
  • 52 Week Low $11.3
  • 50 Day Moving Average 14.98
  • 200 Day Moving Average 14.65
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aurinia Pharmaceuticals Inc (AUPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aurinia Pharmaceuticals Inc (AUPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$50.03 million-$0.05-$0.2075.16%
2020-09-302020-11-10$N/A-$0.28-$0.24-19.15%
2020-06-302020-08-11$N/A-$0.26-$0.23-12.51%
2020-03-312020-05-14$30000-$0.15-$0.2743.93%
2019-12-312020-03-05$29000-$0.78-$0.20-281.79%
2019-09-302019-11-14$230000-$0.21-$0.19-11.52%
2019-06-302019-08-06$29000-$0.17-$0.16-7.59%
2019-03-312019-05-14$30000-$0.14-$0.154.11%
2018-12-312019-03-19$29000-$0.17-$0.16-6.25%
2018-09-302018-11-08$375000-$0.21-$0.18-17.98%
2018-06-302018-08-09$29000-$0.19-$0.14-31.94%
2018-03-312018-05-10$30000-$0.18-$0.16-13.71%
2017-12-312018-03-15$31000-$0.04-$0.1471.77%
2017-09-302017-11-14$29000-$0.16-$0.14-11.11%
2017-06-302017-08-10$329000-$0.03-$0.1376.92%
2017-03-312017-05-15$31000-$0.92-$0.12-693.1%
2016-12-312017-03-09$30000-$0.21-$0.11-85.35%
2016-09-302016-11-04$31000-$0.21-$0.15-42.37%
2016-06-302016-08-05$55000-$0.10-$0.116.28%
2016-03-312016-05-11$57000-$0.13-$0.147.14%
2015-12-312016-03-18$57000-$0.13-$0.143.7%
2015-09-302015-11-13$57000-$0.16-$0.2227.27%
2015-06-302015-08-04$59000-$0.02-$0.2090%
2015-03-312015-05-15$62000-$0.27-$0.14-92.86%
2014-12-312015-03-30$68000-$0.15-$0.12-25%
2014-09-302014-11-12$72000-$0.08
2014-06-302014-08-15$71000-$0.13
2014-03-312014-05-16$67000-$0.24
2013-12-312014-03-28$702249.84$0.11
2013-09-302013-11-22$84384.09-$0.45
2013-06-302013-08-14$83833.48-$0.25
2013-03-312013-05-16$87529.5-$0.20
2012-09-302012-11-14$87549.63-$0.49
2008-12-312009-03-27$585963.18-$2.50-$2.00-25%
2008-09-302008-11-14$2.69 million-$2.00-$2.5020%
2008-06-302008-08-06$553324.85-$2.50-$2.500%
2008-03-312008-05-06$564272.49-$2.50-$4.0037.5%
2007-12-312008-03-18$608006.42-$4.00-$4.5011.11%
2007-09-302007-11-06$554715.08-$3.50-$4.8327.54%
2007-06-302007-08-14$432601.29-$4.50-$4.500%
2007-03-312007-05-09$604253.11-$4.00-$4.7515.79%
2006-12-312007-03-16$759070.25-$4.50-$4.836.83%
2006-09-302006-11-14$519853.01-$4.00-$4.5011.11%
2006-06-302006-08-03$935374.15-$4.00-$4.000%
2006-03-312006-05-15$1.37 million-$3.00-$6.5053.85%
2005-12-312006-03-14$367924.53-$5.50-$4.57-20.35%
2005-09-302005-11-04$262185.16-$4.00-$3.00-33.33%
2005-06-302005-08-09$203998.37-$5.50-$6.5015.38%
2005-03-312005-05-13$317539.07-$5.50-$7.0021.43%
2004-12-312005-03-02$205320.03-$6.50-$6.500%
2004-09-302004-11-10$262261.31-$6.00-$6.000%
2004-06-302004-08-10$255063.77-$3.00-$3.257.69%
2004-03-312004-05-13$468046.12-$2.50-$4.0037.5%
2003-12-312004-03-29$314572.09-$5.50-$3.50-57.14%
2003-09-302003-11-25$306771.14-$4.00-$3.75-6.67%
2003-06-302003-08-25$6.53 million$1.00$3.00-66.67%
2003-03-312003-05-23$215925.35-$4.50-$3.00-50%
2002-12-312003-03-11$206650.98-$3.50-$2.00-75%
2002-09-302002-11-26$4.19 million$3.00$0.00

Aurinia Pharmaceuticals Inc (AUPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aurinia Pharmaceuticals Inc (AUPH) Chart:

Aurinia Pharmaceuticals Inc (AUPH) News:

Below you will find a list of latest news for Aurinia Pharmaceuticals Inc (AUPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aurinia Pharmaceuticals Inc (AUPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-1930CALL0 0911.75TRUE00
2025-12-1940CALL0 0755.2TRUE00
2025-12-1950CALL0 0604.9TRUE00
2025-12-1960CALL0 0572.97TRUE00
2025-12-1978.05CALL0 1492.51TRUE00
2025-12-1980CALL0 00TRUE00
2025-12-1995.58CALL0 1237.61TRUE00
2025-12-19100CALL0 0253.97TRUE00
2025-12-19110CALL0 0177.35TRUE00
2025-12-19123.3CALL1 49141.6TRUE3.30
2025-12-19132.84CALL1 54181.71TRUE2.840
2025-12-19142.6CALL0 1540TRUE00
2025-12-19151CALL9 20656.32TRUE00
2025-12-19160.3CALL4 111735.56FALSE-0.02-0.06
2025-12-19170.05CALL10 15944.31FALSE-0.05-0.5
2025-12-19180.04CALL2 21965.18FALSE-0.01-0.2
2025-12-19190.03CALL0 68217.44FALSE00
2025-12-19200.04CALL0 77140.62FALSE00
2025-12-19210.05CALL0 42382.18FALSE00
2025-12-1930PUT0 01416.72FALSE00
2025-12-1940PUT0 01156.6FALSE00
2025-12-1950PUT0 0975.22FALSE00
2025-12-1960PUT0 0836.21FALSE00
2025-12-1970PUT0 0336.58FALSE00
2025-12-1980PUT0 0628.08FALSE00
2025-12-1990PUT0 0771.07FALSE00
2025-12-19100PUT0 0233.57FALSE00
2025-12-19110.03PUT0 20364.07FALSE00
2025-12-19120.11PUT0 2187.28FALSE00
2025-12-19131.35PUT0 10207.4FALSE00
2025-12-19140.14PUT0 62158.84FALSE00
2025-12-19150.18PUT0 24866.03FALSE00
2025-12-19160.58PUT0 173126.38TRUE00
2025-12-19170PUT0 061.38TRUE00
2025-12-19183.15PUT0 1199.84TRUE00
2025-12-19190PUT0 00TRUE00
2025-12-19200PUT0 00TRUE00
2025-12-19210PUT0 0176.1TRUE00
2026-01-16111.1CALL0 0538.05TRUE00
2026-01-1620CALL0 0480.68TRUE00
2026-01-16311.74CALL0 187380.26TRUE00
2026-01-1640CALL0 0314.13TRUE00
2026-01-16510.1CALL0 230278.33TRUE00
2026-01-1666.85CALL0 29213TRUE00
2026-01-1678.85CALL0 419152.54TRUE00
2026-01-1687.5CALL0 212174.52TRUE00
2026-01-1695.75CALL0 497156.44TRUE00
2026-01-16106CALL0 204390.05TRUE00
2026-01-16114.77CALL1 3430TRUE4.770
2026-01-16124CALL60 576166.92TRUE00
2026-01-16132.8CALL0 3270TRUE00
2026-01-16141.35CALL0 44547.61TRUE00
2026-01-16151.42CALL2 382947.9TRUE-0.08-0.05
2026-01-16161.02CALL0 8839.84FALSE00
2026-01-16170.6CALL2 83853.01FALSE-0.15-0.2
2026-01-16180.42CALL1 9757.59FALSE0.020.05
2026-01-16190.15CALL0 19102.15FALSE00
2026-01-16200.15CALL10 167258.55FALSE00
2026-01-16210.07CALL0 1677.19FALSE00
2026-01-1610PUT0 00FALSE00
2026-01-1620PUT0 00FALSE00
2026-01-1630PUT0 26651.33FALSE00
2026-01-1640PUT0 0528.3FALSE00
2026-01-1650PUT0 550577.17FALSE00
2026-01-1660PUT0 2380.95FALSE00
2026-01-1670.05PUT0 1396329.83FALSE00
2026-01-1680.01PUT0 93222.53FALSE00
2026-01-1690.32PUT0 202249.74FALSE00
2026-01-16100.3PUT0 313179.99FALSE00
2026-01-16110.06PUT0 2397.26FALSE00
2026-01-16120.05PUT0 27690.14FALSE00
2026-01-16130.32PUT1 1973.26FALSE0.320
2026-01-16140.25PUT60 88849.52FALSE-0.15-0.38
2026-01-16150.56PUT0 27675.01FALSE00
2026-01-16161.24PUT0 16338.67TRUE00
2026-01-16172.2PUT0 22047.62TRUE00
2026-01-16180PUT0 095.21TRUE00
2026-01-16190PUT0 061.75TRUE00
2026-01-16204.28PUT0 1000TRUE00
2026-01-16210PUT0 00TRUE00
2026-04-1710CALL0 0376.47TRUE00
2026-04-1720CALL0 0194.59TRUE00
2026-04-1730CALL0 0119.07TRUE00
2026-04-1748.45CALL0 190TRUE00
2026-04-1750CALL0 0123.46TRUE00
2026-04-1760CALL0 0103.47TRUE00
2026-04-1776CALL0 794.08TRUE00
2026-04-1786.5CALL0 51094.49TRUE00
2026-04-1797.4CALL0 2084.02TRUE00
2026-04-17105.7CALL0 95088.63TRUE00
2026-04-17115.27CALL1 17057.16TRUE5.270
2026-04-17124.35CALL0 6048.05TRUE00
2026-04-17133.51CALL0 8948.57TRUE00
2026-04-17143.1CALL0 4351.7TRUE00
2026-04-17152.91CALL0 36247.09TRUE00
2026-04-17162.25CALL74 21460.52FALSE-0.1-0.04
2026-04-17171.6CALL0 26257.67FALSE00
2026-04-17181.25CALL5 22153.04FALSE-0.19-0.13
2026-04-17191CALL0 6152.08FALSE00
2026-04-17200.75CALL1 8352.46FALSE0.750
2026-04-17210.75CALL2 18958.18FALSE0.250.5
2026-04-17250.4CALL0 2176.83FALSE00
2026-04-1710PUT0 00FALSE00
2026-04-1720PUT0 0460.55FALSE00
2026-04-1730PUT0 0341.64FALSE00
2026-04-1740PUT0 0277.2FALSE00
2026-04-1750PUT0 0233.31FALSE00
2026-04-1760PUT0 0200.12FALSE00
2026-04-1770PUT0 0189.37FALSE00
2026-04-1780.45PUT0 503150.99FALSE00
2026-04-1790.7PUT0 1144.22FALSE00
2026-04-17100.56PUT0 61495.06FALSE00
2026-04-17110.67PUT0 2296.7FALSE00
2026-04-17120.7PUT0 10986.34FALSE00
2026-04-17131.05PUT0 6082.91FALSE00
2026-04-17141.57PUT1 10171.09FALSE1.570
2026-04-17151.93PUT0 3886.94FALSE00
2026-04-17162.2PUT0 9680.81TRUE00
2026-04-17172.61PUT10 7154.97TRUE2.610
2026-04-17184.1PUT0 132.28TRUE00
2026-04-17190PUT0 050.43TRUE00
2026-04-17200PUT0 047.21TRUE00
2026-04-17210PUT0 046.99TRUE00
2026-04-17250PUT0 00TRUE00
2026-07-17510CALL0 10TRUE00
2026-07-1770CALL0 00TRUE00
2026-07-1780CALL0 00TRUE00
2026-07-1790CALL0 048.39TRUE00
2026-07-17106.6CALL0 146.75TRUE00
2026-07-17110CALL0 078.49TRUE00
2026-07-17120CALL0 063.82TRUE00
2026-07-17134.4CALL0 361.15TRUE00
2026-07-17140CALL0 053.94TRUE00
2026-07-17152.89CALL0 746.45TRUE00
2026-07-17162.58CALL0 161.63FALSE00
2026-07-17172.4CALL0 2451.97FALSE00
2026-07-17180CALL0 072.86FALSE00
2026-07-17190CALL0 064.04FALSE00
2026-07-17201.6CALL0 248.23FALSE00
2026-07-17211CALL0 250.02FALSE00
2026-07-17220CALL0 051.2FALSE00
2026-07-17230CALL0 066.74FALSE00
2026-07-17240CALL0 083.64FALSE00
2026-07-17250CALL0 080.64FALSE00
2026-07-1750PUT0 0185.33FALSE00
2026-07-1770PUT0 0171.38FALSE00
2026-07-1780PUT0 0124.56FALSE00
2026-07-1790PUT0 0122.08FALSE00
2026-07-17100PUT0 0108.63FALSE00
2026-07-17110PUT0 0111.56FALSE00
2026-07-17120PUT0 0112.82FALSE00
2026-07-17130PUT0 0115.52FALSE00
2026-07-17140PUT0 0120.81FALSE00
2026-07-17150PUT0 052.52FALSE00
2026-07-17162.5PUT0 1057.62TRUE00
2026-07-17170PUT0 048.31TRUE00
2026-07-17183.84PUT0 140.88TRUE00
2026-07-17190PUT0 055.57TRUE00
2026-07-17200PUT0 052.46TRUE00
2026-07-17210PUT0 041.34TRUE00
2026-07-17220PUT0 059.61TRUE00
2026-07-17230PUT0 063.77TRUE00
2026-07-17248.47PUT0 151.25TRUE00
2026-07-17250PUT0 048.94TRUE00
2027-01-1539.7CALL0 5112.96TRUE00
2027-01-15510.2CALL0 400TRUE00
2027-01-1578.9CALL0 3370TRUE00
2027-01-15107.2CALL0 41755.92TRUE00
2027-01-15125.85CALL0 44564.64TRUE00
2027-01-15154.2CALL0 23951.15TRUE00
2027-01-15202.4CALL112 67053.63FALSE0.20.09
2027-01-15251.35CALL0 107454.17FALSE00
2027-01-15300.7CALL0 264.04FALSE00
2027-01-1530PUT0 10FALSE00
2027-01-1550.5PUT0 100FALSE00
2027-01-1570.75PUT0 30694.75FALSE00
2027-01-15101.2PUT0 58100.26FALSE00
2027-01-15122.02PUT0 254120.14FALSE00
2027-01-15153.04PUT0 45155.75FALSE00
2027-01-15205.57PUT0 33150.13TRUE00
2027-01-15250PUT0 045.31TRUE00
2027-01-15300PUT0 00TRUE00
2028-01-2130CALL0 00TRUE00
2028-01-2150CALL0 062.24TRUE00
2028-01-2189CALL0 1163.22TRUE00
2028-01-21107.25CALL0 1456.69TRUE00
2028-01-21126CALL0 18256.22TRUE00
2028-01-21155.9CALL0 850.03TRUE00
2028-01-21174.3CALL0 6149.79FALSE00
2028-01-21203.75CALL0 1048.57FALSE00
2028-01-21220CALL0 048.37FALSE00
2028-01-21252.2CALL0 7548.51FALSE00
2028-01-21300CALL0 076.29FALSE00
2028-01-2130PUT0 00FALSE00
2028-01-2150PUT0 00FALSE00
2028-01-2180PUT0 0161.89FALSE00
2028-01-21102.01PUT0 70123.68FALSE00
2028-01-21123.8PUT0 198.12FALSE00
2028-01-21153.08PUT0 250.79FALSE00
2028-01-21174.6PUT0 1048.62TRUE00
2028-01-21200PUT0 048.61TRUE00
2028-01-21220PUT0 048.95TRUE00
2028-01-21250PUT0 044.36TRUE00
2028-01-21300PUT0 046.45TRUE00

Latest AUPH Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST10$10.135
Jun 13, 2022 7:59 PM EST35$10.14

Aurinia Pharmaceuticals Inc (AUPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506618001065/0000315066-18-001065-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506619000891/0000315066-19-000891-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506620000811/0000315066-20-000811-index.htm
2017-05-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517001237/0000921895-17-001237-index.htm
2017-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517002488/0000921895-17-002488-index.htm
2019-01-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189519000115/0000921895-19-000115-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000108514620000766/0001085146-20-000766-index.htm
2019-04-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919020260/0001104659-19-020260-index.htm
2019-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919033560/0001104659-19-033560-index.htm
2019-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919063369/0001104659-19-063369-index.htm
2019-12-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070670/0001104659-19-070670-index.htm
2019-12-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070762/0001104659-19-070762-index.htm
2019-12-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919071472/0001104659-19-071472-index.htm
2019-12-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919073834/0001104659-19-073834-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000110465920007143/0001104659-20-007143-index.htm
2020-07-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920086013/0001104659-20-086013-index.htm
2020-10-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920113903/0001104659-20-113903-index.htm
2017-07-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000114036117027184/0001140361-17-027184-index.htm
2017-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001041/0001157523-17-001041-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001103/0001157523-17-001103-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001104/0001157523-17-001104-index.htm
2017-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001401/0001157523-17-001401-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001558/0001157523-17-001558-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001561/0001157523-17-001561-index.htm
2017-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001643/0001157523-17-001643-index.htm
2017-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001712/0001157523-17-001712-index.htm
2017-06-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001796/0001157523-17-001796-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001833/0001157523-17-001833-index.htm
2017-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001937/0001157523-17-001937-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002350/0001157523-17-002350-index.htm
2017-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002443/0001157523-17-002443-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002536/0001157523-17-002536-index.htm
2017-10-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002726/0001157523-17-002726-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317003100/0001157523-17-003100-index.htm
2018-01-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000022/0001157523-18-000022-index.htm
2018-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000271/0001157523-18-000271-index.htm
2018-02-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000404/0001157523-18-000404-index.htm
2018-03-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000566/0001157523-18-000566-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001088/0001157523-18-001088-index.htm
2018-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001332/0001157523-18-001332-index.htm
2018-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001334/0001157523-18-001334-index.htm
2018-07-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001402/0001157523-18-001402-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001785/0001157523-18-001785-index.htm
2018-09-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001977/0001157523-18-001977-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318002387/0001157523-18-002387-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000099/0001157523-19-000099-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000428/0001157523-19-000428-index.htm
2019-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000461/0001157523-19-000461-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000601/0001157523-19-000601-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000650/0001157523-19-000650-index.htm
2019-04-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000799/0001157523-19-000799-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000945/0001157523-19-000945-index.htm
2019-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001193/0001157523-19-001193-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001219/0001157523-19-001219-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001334/0001157523-19-001334-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001384/0001157523-19-001384-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001414/0001157523-19-001414-index.htm
2019-06-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001429/0001157523-19-001429-index.htm
2019-06-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001445/0001157523-19-001445-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001535/0001157523-19-001535-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001723/0001157523-19-001723-index.htm
2019-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002052/0001157523-19-002052-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002143/0001157523-19-002143-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002221/0001157523-19-002221-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002261/0001157523-19-002261-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002270/0001157523-19-002270-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002316/0001157523-19-002316-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002335/0001157523-19-002335-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000260/0001157523-20-000260-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000305/0001157523-20-000305-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000339/0001157523-20-000339-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000352/0001157523-20-000352-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000361/0001157523-20-000361-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000398/0001157523-20-000398-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000535/0001157523-20-000535-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000571/0001157523-20-000571-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000743/0001157523-20-000743-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000804/0001157523-20-000804-index.htm
2020-06-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000849/0001157523-20-000849-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000869/0001157523-20-000869-index.htm
2020-06-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000876/0001157523-20-000876-index.htm
2020-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000921/0001157523-20-000921-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001008/0001157523-20-001008-index.htm
2020-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001015/0001157523-20-001015-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001168/0001157523-20-001168-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001232/0001157523-20-001232-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001271/0001157523-20-001271-index.htm
2020-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001285/0001157523-20-001285-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001306/0001157523-20-001306-index.htm
2020-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001337/0001157523-20-001337-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001378/0001157523-20-001378-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001411/0001157523-20-001411-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517169703/0001193125-17-169703-index.htm
2017-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517176713/0001193125-17-176713-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517254546/0001193125-17-254546-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517342556/0001193125-17-342556-index.htm
2018-01-04F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518002955/0001193125-18-002955-index.htm
2018-01-04F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312518003036/0001193125-18-003036-index.htm
2018-03-26F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518096084/0001193125-18-096084-index.htm
2018-04-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518108933/0001193125-18-108933-index.htm
2018-06-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000119312518188267/0001193125-18-188267-index.htm
2018-11-30SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339932/0001193125-18-339932-index.htm
2018-11-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339945/0001193125-18-339945-index.htm
2019-09-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244954/0001193125-19-244954-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244975/0001193125-19-244975-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308631/0001193125-19-308631-index.htm
2019-12-09SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308641/0001193125-19-308641-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519309672/0001193125-19-309672-index.htm
2019-12-10SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519310256/0001193125-19-310256-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519312201/0001193125-19-312201-index.htm
2019-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519316575/0001193125-19-316575-index.htm
2020-05-29F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520155700/0001193125-20-155700-index.htm
2020-05-29F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312520155850/0001193125-20-155850-index.htm
2020-06-17F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520171378/0001193125-20-171378-index.htm
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2020-07-22SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197126/0001193125-20-197126-index.htm
2020-07-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197784/0001193125-20-197784-index.htm
2020-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197855/0001193125-20-197855-index.htm
2019-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390019018908/0001213900-19-018908-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390020003597/0001213900-20-003597-index.htm
2018-03-1540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828018003228/0001628280-18-003228-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006544/0001628280-18-006544-index.htm
2018-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006852/0001628280-18-006852-index.htm
2018-05-176-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006878/0001628280-18-006878-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018010933/0001628280-18-010933-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018013983/0001628280-18-013983-index.htm
2019-03-1940-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828019003130/0001628280-19-003130-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019006728/0001628280-19-006728-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019007420/0001628280-19-007420-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019010124/0001628280-19-010124-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828019011709/0001628280-19-011709-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019014209/0001628280-19-014209-index.htm
2020-03-0540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828020003036/0001628280-20-003036-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020005759/0001628280-20-005759-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020007783/0001628280-20-007783-index.htm
2020-06-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828020009166/0001628280-20-009166-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020012430/0001628280-20-012430-index.htm
2018-03-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999518000708/9999999995-18-000708-index.htm
2020-06-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999520001488/9999999995-20-001488-index.htm